Nexplanon:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DID2015API204)
◆英語タイトル:Nexplanon-API Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DID2015API204
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD1,000 ⇒換算¥109,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Nexplanon:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015]についてメールでお問い合わせはこちら
当調査レポートでは、Nexplanon医薬品市場について調査・分析し、医薬品の概要、世界販売量予測、作用機序、薬力学的特性、薬物動態学的特性、アメリカ及びヨーロッパでの市販状況、特許情報、世界各地域別APIメーカー分析情報などを以下の構成でお届けいたします。※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。

・医薬品の概要
・世界販売量予測データ
・医薬品の説明
・作用機序(MOA)
・薬力学的特性
・薬物動態学的特性
・市販状況:アメリカ、ヨーロッパ
・特許情報
・特許権及び独占権(Exclusivity)存続期間
・グローバルAPIメーカー:地域別分析
・企業概要
*** レポート概要(サマリー)***

Summary
DelveInsight’s, Nexplanon-API Insights, 2015,report provides Nexplanon marketed details and API Manufacturers details across the globe along with the location. DelveInsight’s report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Nexplanon. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the Nexplanon Global sales forecasts data till 2016.
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

[Data Sources]
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


Scope

• A review of the Nexplanon based on information derived from company and industry-specific sources
• Coverage of the Marketed data of the Nexplanon on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for drug with location details.
• Patent Expiry Timeline and Exclusivity Details
• Global Forecasted Sales Figure from 2012-2016
• Qualitative and quantitative assessment of market space


*** レポート目次(コンテンツ)***

Table of Contents

• Drug Overview
• Global Sales Assessment
• Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
• Marketed Details for the United States
• Marketed Details for the Europe
• Patent Information
• Patent and Exclusivity Expiry Assessment United States (US)
• Patent Numbers and Expiry Details
• Patent Details
• Global API Manufacturers Assessment
• The United States Drug Master File (US DMF)
• The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
• The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
• The Active Pharmaceutical Ingredient (API) Manufacturers by Region
• The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
• Generic Players
• Company Profile
• Summary
• Company Financials
• References
• Appendix
• Methodology
• About DelveInsight
• Contact Us
• Disclaimer

List of Tables
• Nexplanon, Market, Global Sales (in USD), 2015
• Nexplanon, Description
• Nexplanon, Marketed Details the United States (US)
• Nexplanon, Marketed Details the Europe (EU)
• Nexplanon, Patent/Exclusivity Expiry (Year), 2015
• Nexplanon, Patent Number Specific Patent Expiry (Year), 2015
• Nexplanon, Patent Details
• Nexplanon, the United States Drug Master File (US DMF), 2015
• Nexplanon, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2015
• Nexplanon, the API Manufacturers, China, 2015
• Nexplanon, the API Manufacturers, India, 2015
• Nexplanon, the API Manufacturers by the US DMF Status, 2015
• Nexplanon, the API Manufacturers by Region, 2015
• Nexplanon, the API Manufacturers by Location/Countries, 2015
• Nexplanon, Generic Players, 2015
• Company Overview, 2015

List of Figures
• Nexplanon, Market, Global Sales (in million USD), 2015
• Nexplanon, Global Sales % Change, 2015
• Nexplanon, Patent/Exclusivity Expiry (Year), 2015
• Nexplanon, Patent Number Specific Patent Expiry (Year), 2015
• Nexplanon, the API Manufacturers by the US DMF Status (%), 2015
• Nexplanon, the API Manufacturers by Region, 2015
• Nexplanon, the API Manufacturers by Location/Countries, 2015
• Nexplanon, Generic Players, 2015

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界のマプロチリン市場2017
    Notes:Sales, means the sales volume of Maprotiline Revenue, means the sales value of Maprotiline This report studies sales (consumption) of Maprotiline in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenu …
  • 電子設計自動化ツール(EDA)の世界市場予測2018-2023
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Electronic Design Automation Tools (EDA) market for 2018-2023. Electronic design automation (EDA) is a category of software tools for designing electronic systems such as int …
  • 真菌血症(Fungemia):治療薬開発パイプライン動向2014
    SUMMARY DelveInsight’s,“ Fungemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fungemia. This report provides information on the …
  • UNID – Goclaw Apartments Development – Masovian:建設プロジェクト概要
    World Market Intelligence's "UNID – Goclaw Apartments Development – Masovian - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the UNID – Goclaw Apartments Development – Masovian construction project. World Market Intelli …
  • 世界のボールボンディングゴールドワイヤー市場2017
    Ball Bonding Gold Wire Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, …
  • 世界及び中国のガラス戸市場2016
    The 'Global and Chinese Glass Doors Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Glass Doors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Glass Doors manufacturers an …
  • ジャンプスターターの世界市場2016
    The Global Jump Starter Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Jump Starter industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Ju …
  • 韓国における縫合糸市場
    South Korea Surgical Sutures Market Outlook to 2020 Summary GlobalData’s new report, "South Korea Surgical Sutures Market Outlook to 2020", provides key market data on the South Korea Surgical Sutures market. The report provides value, in millions of US dollars, volume (in units) and average prices …
  • DBV Technologies (DBV)(製薬・医療分野):企業M&A動向
    Summary DBV Technologies (DBV) is a pharmaceutical and healthcare company. It carries out the development of products for the diagnosis and treatment of food allergies. The company develops and markets non invasive epicutaneous delivery technology and products for healthcare markets. Its products li …
  • 熱硬化性重合体(TP)の世界市場
    In this report, the global Thermosetting polymer (TP) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DID2015API204 )"Nexplanon:医薬品の世界市場規模、市販状況、特許、APIメーカー分析2015" (英文:Nexplanon-API Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。